Figure S5 from RAS Mutation–Specific Responses to Paralog- and State-Selective RAS Inhibitors
Abstract
Sensitivity to any single RAS-targeted inhibitor is restricted to the subset of RAS(MUT)-specific inhibitor-sensitive tumors
Fields of Study & Subjects
Melanoma and MAPK Pathways
Protein Degradation and Inhibitors
PI3K/AKT/mTOR signaling in cancer
Publication details
- Publication date
- 2 January 2026